ReSPECT-GBM Update at CNS

by | Oct 1, 2024 | GBM

Plus Therapeutics presented an update on the ongoing ReSPECT-GBM Phase 1/2 clinical trial, evaluating Rhenium (186Re) Obisbemeda for the treatment of recurrent glioblastoma at the 2024 Congress of Neurological Surgeons (CNS) Annual Meeting yesterday. Key...

Caregiver Support Group

by | Sep 12, 2024 | GBM

Join us at the @HeadfortheCure Caregiver Conversations support group! We will discuss our ReSPECT-GBM clinical trial for Glioblastoma, patient resources, and upcoming events. respect-trials.com/gbm Join Brains for the Cure the 2nd Thursday of each month on Zoom at 7...

GBM Fight

by | Jul 19, 2024 | GBM

“A lot of the battles that [GBM] picks are people that are truly going to fight back and give hope to the next patient…” ✊ Watch the full interview with Olympic Athlete & Brain Cancer Champion Scott Hamilton: https://bit.ly/4bKiufQ Social Media:...

ABTA Featured Clinical Trial

by | Jun 12, 2024 | GBM

📣 ReSPECT-GBM Clinical Trial is now a @the_abta Featured Clinical Study Check it out here: https://bit.ly/45iB7WE The American Brain Tumor Association’s (ABTA) Featured Clinical Trial Program is part of their ongoing efforts to educate and support patients with brain...

Musella GBM Patient Webinar

by | May 6, 2024 | GBM

➡️ GLIOBLASTOMA PATIENT WEBINAR ⬅️ Join us as the @MusellaFoundation hosts Dr. Andrew Brenner and Dr. Marc Hedrick in a discussion about the ReSPECT-GBM Phase 2 Clinical Trial for Recurrent Glioblastoma. The webinar will take place May 20 2pm EST with a recording to...

Plus Approach

by | Apr 3, 2024 | GBM

Plus Therapeutics’ novel approach to treating Glioblastoma overcomes the limitations of all three currently employed treatment modalities. Leveraging established, targeted delivery techniques, we seek to inject high doses of radiation directly into or near a...